These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24788413)

  • 1. Effect of added alkalizer and surfactant on dissolution and absorption of the potassium salt of a weakly basic poorly water-soluble drug.
    Mahjour M; Kesisoglou F; Cruanes M; Xu W; Zhang D; Maguire TJ; Rosen LA; Templeton AC; Kress MH
    J Pharm Sci; 2014 Jun; 103(6):1811-8. PubMed ID: 24788413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and in vivo human bioavailability of dissolving tablets containing a self-nanoemulsifying itraconazole solid dispersion without precipitation in simulated gastrointestinal fluid.
    Piao ZZ; Choe JS; Oh KT; Rhee YS; Lee BJ
    Eur J Pharm Sci; 2014 Jan; 51():67-74. PubMed ID: 24012590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and evaluation of in vivo bioavailability in beagle dogs of bilayer tablet consisting of immediate release nanosuspension and sustained release layers of rebamipide.
    Jin G; Ngo HV; Wang J; Cui JH; Cao QR; Park C; Jung M; Lee BJ
    Int J Pharm; 2022 May; 619():121718. PubMed ID: 35381311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation of solid dosage forms to overcome gastric pH interaction of the factor Xa inhibitor, BMS-561389.
    Badawy SI; Gray DB; Zhao F; Sun D; Schuster AE; Hussain MA
    Pharm Res; 2006 May; 23(5):989-96. PubMed ID: 16715389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical properties and in vivo bioavailability in human volunteers of isradipine using controlled release matrix tablet containing self-emulsifying solid dispersion.
    Tran PH; Tran TT; Piao ZZ; Vo TV; Park JB; Lim J; Oh KT; Rhee YS; Lee BJ
    Int J Pharm; 2013 Jun; 450(1-2):79-86. PubMed ID: 23612354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of novel fast-dissolving tacrolimus solid dispersion-loaded prolonged release tablet.
    Cho JH; Kim YI; Kim DW; Yousaf AM; Kim JO; Woo JS; Yong CS; Choi HG
    Eur J Pharm Sci; 2014 Apr; 54():1-7. PubMed ID: 24388864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human.
    Wu Y; Loper A; Landis E; Hettrick L; Novak L; Lynn K; Chen C; Thompson K; Higgins R; Batra U; Shelukar S; Kwei G; Storey D
    Int J Pharm; 2004 Nov; 285(1-2):135-46. PubMed ID: 15488686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced bioavailability of a poorly water-soluble weakly basic compound using a combination approach of solubilization agents and precipitation inhibitors: a case study.
    Li S; Pollock-Dove C; Dong LC; Chen J; Creasey AA; Dai WG
    Mol Pharm; 2012 May; 9(5):1100-8. PubMed ID: 22376012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol-polysorbate 80 solid dispersion carrier system.
    Dannenfelser RM; He H; Joshi Y; Bateman S; Serajuddin AT
    J Pharm Sci; 2004 May; 93(5):1165-75. PubMed ID: 15067693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of surfactants, gastric emptying, and dosage form on supersaturation of dipyridamole in an in vitro model simulating the stomach and duodenum.
    Mitra A; Fadda HM
    Mol Pharm; 2014 Aug; 11(8):2835-44. PubMed ID: 25025699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solubility enhancement of desloratadine by solid dispersion in poloxamers.
    Kolašinac N; Kachrimanis K; Homšek I; Grujić B; Ðurić Z; Ibrić S
    Int J Pharm; 2012 Oct; 436(1-2):161-70. PubMed ID: 22772487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles.
    Wong SM; Kellaway IW; Murdan S
    Int J Pharm; 2006 Jul; 317(1):61-8. PubMed ID: 16647232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
    Fei Y; Kostewicz ES; Sheu MT; Dressman JB
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between dissolution characteristics and absorption of methaqualone from solid dosage forms.
    Chemburkar PB; Smyth RD; Buehler JD; Shah PB; Joslin RS; Polk A; Reavey-Cantwell NH
    J Pharm Sci; 1976 Apr; 65(4):529-33. PubMed ID: 1271252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an enhanced formulation to minimize pharmacokinetic variabilities of a weakly basic drug compound.
    Pu YE; Menger R; Tong Z; Gaebele T
    Pharm Dev Technol; 2022 Apr; 27(4):406-413. PubMed ID: 35502986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microwave-generated bionanocomposites for solubility and dissolution enhancement of poorly water-soluble drug glipizide: in-vitro and in-vivo studies.
    Kushare SS; Gattani SG
    J Pharm Pharmacol; 2013 Jan; 65(1):79-93. PubMed ID: 23215691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examination of the impact of a range of Pluronic surfactants on the in-vitro solubilisation behaviour and oral bioavailability of lipidic formulations of atovaquone.
    Sek L; Boyd BJ; Charman WN; Porter CJ
    J Pharm Pharmacol; 2006 Jun; 58(6):809-20. PubMed ID: 16734982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of surfactants on the dissolution behavior of amorphous formulations.
    Mah PT; Peltonen L; Novakovic D; Rades T; Strachan CJ; Laaksonen T
    Eur J Pharm Biopharm; 2016 Jun; 103():13-22. PubMed ID: 26955750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on preparation of carbamazepine (CBZ) supersaturatable self-microemulsifying (S-SMEDDS) formulation and relative bioavailability in beagle dogs.
    Zhang N; Zhang W; Jin Y; Quan DQ
    Pharm Dev Technol; 2011 Aug; 16(4):415-21. PubMed ID: 20433250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.